Bob Lederer RFL Communications, Inc.

MD want to replace EHRs. Set up med device registries. Google Calico invests $250 M (PRVR 9/8-12/2014)

Pharma Research VIDEO Report is sponsored by the Toluna Healthcare Practice, offering highly engaged physicians, health professionals and ailment sufferers for global research using cutting-edge methodologies, sophisticated, yet easy-to-use analytic tools and specialized products including Pharmacy Intercept, dedicated communities, patient record studies and more.

For more information: http://www.toluna-group.com/about-toluna/industries-we-serve/healthcare/overview
On this PRVR: 1) EHRs have become part and parcel of physician practices, but a good percentages of them want to start their EHR over. 2) Apple lays out legalities with health care app providers. 3) Three prestigious health organizations recommend establishment of registries to assess medical devices. 4) The Affordable Care Act’s 2.3% medical device tax is supposed to cause job losses and sales drops. So, far those expectations look like they are half right. 5) Google Calico puts its money where it counts, matching AbbVie dollar-for-dollar, in exploration of age-related diseases. 6) China’s human clinical trails are said to be extraordinarily populated with impoverished Chinese youth.

Bob Lederer RFL Communications, Inc.

Preventing MD shortages; Getting “Well-Being” in control (PRVR 8/11/14)

This week on Pharma Research VIDEO Report: 1) FutureDocs Forecasting tool looks to help discover the causes of a projected MD shortage. 2) Gallup-Healthways Well-Being 5™ measures, reports and tracks the strongest predictor of health and performance outcomes over time and well-being. 3) PWC expects healthcare insurance pricing won’t increase as much in 2015 as in pre-Obamacare years.  4) Dr Social CEO Claudio Teri claims that the success of TripAdvisor portends solid consumer participation in his physician review service.

Bob Lederer RFL Communications, Inc.

Early ACA Rx trends; IMS Health IPO; Med Payments Getting Easier (PRVR–4/14/2014)

This week on Pharma Research VIDEO Report: 1) Express Scripts details prescription order trends with ACA enrollees in January and February. 2) A Milliman study for CVS Caremark suggests moving specialty drug payment responsibility from medical to pharmacy benefits. 3) IMS Health’s IPO makes common stock available at $20.00 per share. 4) The percentage of people under 65 having difficulty paying their medical bills dropped between 2011 and 2013 due to improved economic conditions. 5) Vermont is moving to implement single player health care and needs to raise $2 billion per year to get it started.

Bob Lederer RFL Communications, Inc.

Med cost up 3-5%; pharmacos cut MD speaker fees; FDA eases adverse event reporting (PRVR–3/10/14)

This week’s Pharma Research VIDEO Report: 1) Costs for medications will rise 3-5% this year, after having dramatically slowed in recent years. 2) Pharmaceutical companies have radically reduced what they pay doctors to speak, well at least many of them have. 3) Generic drug manufacturers will fight FDA proposals that they be required to update their product labels when new information with concerns about branded equivalents appear. 4) FDA will make availability of adverse event reports much easier to find and collect. 5) Health care providers say the Affordable Care Act needs changes and revisions, but overwhelmingly see it as a positive step for U.S. healthcare. 6) The multimillion dollar injectable drug market for chronic conditions like diabetes may be in or a shakeup if Mir Imran’s “Robotic Pill” gets FDA approval. It is in preclinical testing. 7) Media technology company Sticky wins the PM360 award for most innovative company. 8) A press release last week declared the first broadcast medical marijuana commercial. The release pointed to Comcast as the broadcaster. Since the taping of this video, PRVR has learned that this release was part of a misleading campaign. We apologize for this mistaken report.

Here is the link to the commercial:
https://www.marijuanadoctors.com/content/page/view/91

Bob Lederer RFL Communications, Inc.

Comparing Observational MR; Proposed Part D changes; FDA generic Rx initiative; HIMSS reports on HC mobile implementation vs. usage; MDLinx verifying European MDs; Novartis expands clinical data transparency; SAP testing “Medical Insights” cancer patient assistance (PMRVR–3/4/14)

In this Pharma Market Research VIDEO Report:  1) GRACE, an 11-item checklist of data and methods, allows testing of baseline quality criteria for observational research.  2) The CMS is proposing changes to Medicare Part D. The big picture change calls for stopping automatic Medicare coverage of two drug classes; the underlying consideration in the plan could lead to federal government price negotiations with pharmacos (expressly forbidden in legislation that established Part D).  3) The FDA launches a $20 million initiative to test generic drug production, which represents 80% of Rx drugs. India, wiht its $15 billion in annual generic drug production, is a primary focus but China is also in the crosshairs. 4) HIMSS mobile research study investigates its implementation and use by healthcare providers.  5) GfK reports an upsurge in 2013 in purchase of mobile-connected medical devices in top European countries.  6) MDLinx is launching its physician verification service in Europe.  7) The Kaiser Family Foundation reports users of the ACA website were more price-oriented than physician-focused.  8) Novartis says it has extended its pharmaco leadership in clinical trial data transparency.  9) SAP is testing “Medical Insights,” a capability that aids cancer patients by pulling relevant data from many cancer data sources, runs advanced analytics and delivers customized results in real time.